Is Opdivo a chemotherapy drug?
No. Opdivo (nivolumab) is not chemotherapy. It’s an immunotherapy medicine, specifically a PD-1 checkpoint inhibitor, which helps your immune system recognize and attack cancer cells.
What kind of cancer treatment is Opdivo then?
Opdivo is used to treat several cancers by blocking the PD-1 pathway, which can “release the brakes” on immune T-cells. That’s different from chemotherapy, which typically uses cytotoxic drugs to kill rapidly dividing cells (including cancer cells, but also some healthy cells).
Can Opdivo be used “with chemo”?
Yes. Opdivo is sometimes given in combination with chemotherapy regimens, depending on the cancer type and stage. In those cases, chemo is the chemotherapy component, and Opdivo is the immunotherapy component.
What side effects are patients looking for: chemo-like or immunotherapy-like?
Opdivo’s side effects often include immune-related effects (because it changes immune activity), such as inflammation in organs like the lungs, liver, intestines, skin, or endocrine glands. These are different in nature from many common chemotherapy side effects, though some treatments can still cause overlapping issues like fatigue.
How to confirm for your specific prescription
If you tell me the cancer type (and the exact regimen name on your prescription or treatment plan), I can help you determine whether your Opdivo schedule is standalone immunotherapy or combined with actual chemotherapy.